Literature DB >> 30397103

mRNAs biotinylated within the 5' cap and protected against decapping: new tools to capture RNA-protein complexes.

Sylwia Bednarek1,2, Vanesa Madan3, Pawel J Sikorski2, Ralf Bartenschlager3, Joanna Kowalska1, Jacek Jemielity4.   

Abstract

The 5'-terminus of eukaryotic mRNAs comprises a 7-methylguanosine cap linked to the first transcribed nucleotide via a 5'-5' triphosphate bond. This cap structure facilitates numerous interactions with molecules participating in mRNA processing, turnover and RNA translation. Here, we report the synthesis and biochemical properties of a set of biotin-labelled cap analogues modified within the triphosphate bridge and increasing mRNA stability while retaining biological activity. Successful co-transcriptional incorporation of the cap analogues allowed for the quantification of cap-dependent translation efficiency, capping efficiency and the susceptibility to decapping by Dcp2. The utility of such cap-biotinylated RNAs as molecular tool was demonstrated by ultraviolet-cross-linking and affinity capture of protein-RNA complexes. In conclusion, RNAs labelled with biotin via the 5' cap structure can be applied to a variety of biological experiments based on biotin-avidin interaction or by means of biotin-specific antibodies, including protein affinity purification, pull-down assays, in vivo visualization, cellular delivery and many others.This article is part of the theme issue '5' and 3' modifications controlling RNA degradation'.
© 2018 The Author(s).

Entities:  

Keywords:  RNA degradation; biotin; mRNA cap

Mesh:

Substances:

Year:  2018        PMID: 30397103      PMCID: PMC6232584          DOI: 10.1098/rstb.2018.0167

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  41 in total

1.  Functional analysis of mRNA scavenger decapping enzymes.

Authors:  Shin-Wu Liu; Xinfu Jiao; Hudan Liu; Meigang Gu; Christopher D Lima; Megerditch Kiledjian
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

Review 2.  The biotin-(strept)avidin system: principles and applications in biotechnology.

Authors:  E P Diamandis; T K Christopoulos
Journal:  Clin Chem       Date:  1991-05       Impact factor: 8.327

3.  hnRNP C and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region within the 3'NTR of the HCV RNA genome.

Authors:  R R Gontarek; L L Gutshall; K M Herold; J Tsai; G M Sathe; J Mao; C Prescott; A M Del Vecchio
Journal:  Nucleic Acids Res       Date:  1999-03-15       Impact factor: 16.971

4.  Enzymatically stable 5' mRNA cap analogs: synthesis and binding studies with human DcpS decapping enzyme.

Authors:  Marcin Kalek; Jacek Jemielity; Zbigniew M Darzynkiewicz; Elzbieta Bojarska; Janusz Stepinski; Ryszard Stolarski; Richard E Davis; Edward Darzynkiewicz
Journal:  Bioorg Med Chem       Date:  2006-01-23       Impact factor: 3.641

5.  New AdoMet Analogues as Tools for Enzymatic Transfer of Photo-Cross-Linkers and Capturing RNA-Protein Interactions.

Authors:  Fabian Muttach; Florian Mäsing; Armido Studer; Andrea Rentmeister
Journal:  Chemistry       Date:  2017-01-31       Impact factor: 5.236

Review 6.  Fluorescence methods for studying equilibrium macromolecule-ligand interactions.

Authors:  M R Eftink
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

7.  Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.

Authors:  Jeremy R Graff; Bruce W Konicek; Thomas M Vincent; Rebecca L Lynch; David Monteith; Spring N Weir; Phil Schwier; Andrew Capen; Robin L Goode; Michele S Dowless; Yuefeng Chen; Hong Zhang; Sean Sissons; Karen Cox; Ann M McNulty; Stephen H Parsons; Tao Wang; Lillian Sams; Sandaruwan Geeganage; Larry E Douglass; Blake Lee Neubauer; Nicholas M Dean; Kerry Blanchard; Jianyong Shou; Louis F Stancato; Julia H Carter; Eric G Marcusson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS.

Authors:  Joanna Kowalska; Magdalena Lewdorowicz; Joanna Zuberek; Ewa Grudzien-Nogalska; Elzbieta Bojarska; Janusz Stepinski; Robert E Rhoads; Edward Darzynkiewicz; Richard E Davis; Jacek Jemielity
Journal:  RNA       Date:  2008-04-22       Impact factor: 4.942

9.  Site-specific labeling of RNA at internal ribose hydroxyl groups: terbium-assisted deoxyribozymes at work.

Authors:  Lea Büttner; Fatemeh Javadi-Zarnaghi; Claudia Höbartner
Journal:  J Am Chem Soc       Date:  2014-05-23       Impact factor: 15.419

Review 10.  The mRNA cap-binding protein eIF4E in post-transcriptional gene expression.

Authors:  Tobias von der Haar; John D Gross; Gerhard Wagner; John E G McCarthy
Journal:  Nat Struct Mol Biol       Date:  2004-06       Impact factor: 15.369

View more
  3 in total

1.  5' and 3' modifications controlling RNA degradation: from safeguards to executioners.

Authors:  Dominique Gagliardi; Andrzej Dziembowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

2.  Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism.

Authors:  Dorota Kubacka; Mateusz Kozarski; Marek R Baranowski; Radoslaw Wojcik; Joanna Panecka-Hofman; Dominika Strzelecka; Jerome Basquin; Jacek Jemielity; Joanna Kowalska
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-29

Review 3.  Recent Advances in Modified Cap Analogs: Synthesis, Biochemical Properties, and mRNA Based Vaccines.

Authors:  Muthian Shanmugasundaram; Annamalai Senthilvelan; Anilkumar R Kore
Journal:  Chem Rec       Date:  2022-04-14       Impact factor: 6.935

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.